BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38301247)

  • 21. A surgical strategy using a fusion image constructed from 11C-methionine PET, 18F-FDG-PET and MRI for glioma with no or minimum contrast enhancement.
    Ideguchi M; Nishizaki T; Ikeda N; Okamura T; Tanaka Y; Fujii N; Ohno M; Shimabukuro T; Kimura T; Ikeda E; Suga K
    J Neurooncol; 2018 Jul; 138(3):537-548. PubMed ID: 29516344
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preoperative evaluation of 54 gliomas by PET with fluorine-18-fluorodeoxyglucose and/or carbon-11-methionine.
    Kaschten B; Stevenaert A; Sadzot B; Deprez M; Degueldre C; Del Fiore G; Luxen A; Reznik M
    J Nucl Med; 1998 May; 39(5):778-85. PubMed ID: 9591574
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 11C-methionine (MET) and 18F-fluorothymidine (FLT) PET in patients with newly diagnosed glioma.
    Hatakeyama T; Kawai N; Nishiyama Y; Yamamoto Y; Sasakawa Y; Ichikawa T; Tamiya T
    Eur J Nucl Med Mol Imaging; 2008 Nov; 35(11):2009-17. PubMed ID: 18542957
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predicting seizure-free status for temporal lobe epilepsy patients undergoing surgery: prognostic value of quantifying maximal metabolic asymmetry extending over a specified proportion of the temporal lobe.
    Lin TW; de Aburto MA; Dahlbom M; Huang LL; Marvi MM; Tang M; Czernin J; Phelps ME; Silverman DH
    J Nucl Med; 2007 May; 48(5):776-82. PubMed ID: 17475967
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ipsilateral and contralateral thalamic hypometabolism as a predictor of outcome after temporal lobectomy for seizures.
    Newberg AB; Alavi A; Berlin J; Mozley PD; O'Connor M; Sperling M
    J Nucl Med; 2000 Dec; 41(12):1964-8. PubMed ID: 11138679
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 11C-Methionine positron emission tomography for preoperative evaluation of suggestive low-grade gliomas.
    Gumprecht H; Grosu AL; Souvatsoglou M; Dzewas B; Weber WA; Lumenta CB
    Zentralbl Neurochir; 2007 Feb; 68(1):19-23. PubMed ID: 17487804
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epileptic seizures and survival in early disease of grade 2 gliomas.
    Danfors T; Ribom D; Berntsson SG; Smits A
    Eur J Neurol; 2009 Jul; 16(7):823-31. PubMed ID: 19473357
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Seizure characteristics and outcomes in 508 Chinese adult patients undergoing primary resection of low-grade gliomas: a clinicopathological study.
    You G; Sha ZY; Yan W; Zhang W; Wang YZ; Li SW; Sang L; Wang Z; Li GL; Li SW; Song YJ; Kang CS; Jiang T
    Neuro Oncol; 2012 Feb; 14(2):230-41. PubMed ID: 22187341
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development and validation of clinical-radiomics analysis for preoperative prediction of IDH mutation status and WHO grade in diffuse gliomas: a consecutive L-[methyl-11C] methionine cohort study with two PET scanners.
    Zhou W; Wen J; Huang Q; Zeng Y; Zhou Z; Zhu Y; Chen L; Guan Y; Xie F; Zhuang D; Hua T
    Eur J Nucl Med Mol Imaging; 2024 Apr; 51(5):1423-1435. PubMed ID: 38110710
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epileptic versus neuro-oncological focus of management in pediatric patients with concurrent primary brain lesion and seizures: a systematic review.
    Gruber MD; Pindrik J; Damante M; Schulz L; Shaikhouni A; Leonard JR
    J Neurosurg Pediatr; 2023 Nov; 32(5):576-583. PubMed ID: 37728409
    [TBL] [Abstract][Full Text] [Related]  

  • 31. L-(methyl-11C) methionine positron emission tomography for target delineation in resected high-grade gliomas before radiotherapy.
    Grosu AL; Weber WA; Riedel E; Jeremic B; Nieder C; Franz M; Gumprecht H; Jaeger R; Schwaiger M; Molls M
    Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):64-74. PubMed ID: 16111573
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is 11C-flumazenil PET superior to 18FDG PET and 123I-iomazenil SPECT in presurgical evaluation of temporal lobe epilepsy?
    Debets RM; Sadzot B; van Isselt JW; Brekelmans GJ; Meiners LC; van Huffelen AO; Franck G; van Veelen CW
    J Neurol Neurosurg Psychiatry; 1997 Feb; 62(2):141-50. PubMed ID: 9048714
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Surgical, functional, and oncological considerations regarding awake resection for giant diffuse lower-grade glioma of more than 100 cm3.
    Sauvageot S; Boetto J; Duffau H
    J Neurosurg; 2023 Oct; 139(4):934-943. PubMed ID: 36964732
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of focal cortical dysplasia Type IIIa on seizure outcome following anterior mesial temporal lobe resection for the treatment of epilepsy.
    Dührsen L; Sauvigny T; House PM; Stodieck S; Holst B; Matschke J; Schön G; Westphal M; Martens T
    J Neurosurg; 2018 Jun; 128(6):1668-1673. PubMed ID: 28753112
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Surgical outcome in patients with MRI-negative, PET-positive temporal lobe epilepsy.
    Capraz IY; Kurt G; Akdemir Ö; Hirfanoglu T; Oner Y; Sengezer T; Kapucu LO; Serdaroglu A; Bilir E
    Seizure; 2015 Jul; 29():63-8. PubMed ID: 26076845
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Visual and semiquantitative 11C-methionine PET: an independent prognostic factor for survival of newly diagnosed and treatment-naïve gliomas.
    Poetsch N; Woehrer A; Gesperger J; Furtner J; Haug AR; Wilhelm D; Widhalm G; Karanikas G; Weber M; Rausch I; Mitterhauser M; Wadsak W; Hacker M; Preusser M; Traub-Weidinger T
    Neuro Oncol; 2018 Feb; 20(3):411-419. PubMed ID: 29016947
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 18F-fluoro-L-thymidine and 11C-methylmethionine as markers of increased transport and proliferation in brain tumors.
    Jacobs AH; Thomas A; Kracht LW; Li H; Dittmar C; Garlip G; Galldiks N; Klein JC; Sobesky J; Hilker R; Vollmar S; Herholz K; Wienhard K; Heiss WD
    J Nucl Med; 2005 Dec; 46(12):1948-58. PubMed ID: 16330557
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rates of Seizure Freedom After Surgical Resection of Diffuse Low-Grade Gliomas.
    Bonney PA; Boettcher LB; Burks JD; Baker C; Conner AK; Fujii T; Mehta VA; Briggs RG; Sughrue ME
    World Neurosurg; 2017 Oct; 106():750-756. PubMed ID: 28673890
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Surgical target selection in cerebral glioma surgery: linking methionine (MET) PET image fusion and neuronavigation.
    Roessler K; Gatterbauer B; Becherer A; Paul M; Kletter K; Prayer D; Hoeftberger R; Hainfellner J; Asenbaum S; Knosp E
    Minim Invasive Neurosurg; 2007 Oct; 50(5):273-80. PubMed ID: 18058643
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extent of Resection and Residual Tumor Thresholds for Postoperative Total Seizure Freedom in Epileptic Adult Patients Harboring a Supratentorial Diffuse Low-Grade Glioma.
    Still MEH; Roux A; Huberfeld G; Bauchet L; Baron MH; Fontaine D; Blonski M; Mandonnet E; Guillevin R; Guyotat J; Taillandier L; Capelle L; Duffau H; Pallud J
    Neurosurgery; 2019 Aug; 85(2):E332-E340. PubMed ID: 30395304
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.